Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added updates dated 2026-04-02 and 2026-04-03, and removed updates dated 2026-03-26 and 2026-03-27.
    Difference
    0.1%
    Check dated 2026-04-04T19:05:14.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Additions on 2026-03-26 and 2026-03-27 introduce Urinary bladder small cell neuroendocrine carcinoma as a listed condition; deletions on 2026-03-19 and 2026-03-20 remove two previously listed items, updating the study's documented condition scope.
    Difference
    0.1%
    Check dated 2026-03-28T13:47:32.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0; prior revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-21T08:46:54.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Administrative updates to the study record: new update dates posted on 2026-03-12 and 2026-03-13, replacing earlier dates 2026-03-05 and 2026-03-06.
    Difference
    0.1%
    Check dated 2026-03-13T22:58:00.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added entries for 2026-03-05 and 2026-03-06 with Revision: v3.4.3; older 2025 entries and Revision: v3.4.2 were removed.
    Difference
    0.2%
    Check dated 2026-03-06T19:14:53.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.1 to v3.4.2; no visible changes to page content.
    Difference
    0.0%
    Check dated 2026-02-13T12:06:44.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.